Shandong Buchang Pharmaceuticals Co (SHSE:603858) Debt-to-Equity : 0.32 (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Shandong Buchang Pharmaceuticals Co Debt-to-Equity?

Shandong Buchang Pharmaceuticals Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥1,131 Mil. Shandong Buchang Pharmaceuticals Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥2,557 Mil. Shandong Buchang Pharmaceuticals Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥11,564 Mil. Shandong Buchang Pharmaceuticals Co's debt to equity for the quarter that ended in Mar. 2024 was 0.32.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Shandong Buchang Pharmaceuticals Co's Debt-to-Equity or its related term are showing as below:

SHSE:603858' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.12 Med: 0.23 Max: 0.37
Current: 0.32

During the past 13 years, the highest Debt-to-Equity Ratio of Shandong Buchang Pharmaceuticals Co was 0.37. The lowest was 0.12. And the median was 0.23.

SHSE:603858's Debt-to-Equity is ranked worse than
52.06% of 849 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs SHSE:603858: 0.32

Shandong Buchang Pharmaceuticals Co Debt-to-Equity Historical Data

The historical data trend for Shandong Buchang Pharmaceuticals Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Buchang Pharmaceuticals Co Debt-to-Equity Chart

Shandong Buchang Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.20

0.26

0.25

0.26

0.27

Shandong Buchang Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.24	0.27	0.26	0.27	0.32

Competitive Comparison of Shandong Buchang Pharmaceuticals Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Buchang Pharmaceuticals Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shandong Buchang Pharmaceuticals Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Buchang Pharmaceuticals Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Shandong Buchang Pharmaceuticals Co's Debt-to-Equity falls into.

Shandong Buchang Pharmaceuticals Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Shandong Buchang Pharmaceuticals Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1042.376	+	2109.37)	/	11616.994
	=	0.27

Shandong Buchang Pharmaceuticals Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1131.264	+	2556.679)	/	11564.286
	=	0.32

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Shandong Buchang Pharmaceuticals Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Shandong Buchang Pharmaceuticals Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Buchang Pharmaceuticals Co Ltd (SHSE:603858) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

No. 369, Zhonghua West Road, Shandong Province, Heze, CHN, 274000

Website

http://www.buchang.com

Shandong Buchang Pharmaceuticals Co Ltd is a pharmaceuticals company engaged in drug manufacturing. It specializes in the research and development, production and sale of Traditional Chinese patent medicines, supplemented by fields such as hi-tech industry and health industry. The company offers drugs for cardiac and cerebral vascular disease, diabetes, urinary and digestive disease, respiratory disease, gynecological disease and others. Geographically, the company holds its production bases in Shandong, Shaanxi, Hebei and Northeast China, with its marketing network spreading all over the major provinces of China.

Shandong Buchang Pharmaceuticals Co (SHSE:603858) Headlines

No Headlines